← back to search

Carlos U. Corvera

University of California, San Francisco · US
Area of research
Oncology · Hepatology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
35
citations
11,412
works
212
NIH funding
primary concept
email

Recent publications

Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2025cited by 123position: middledoi
Minimally Invasive Distal Pancreatectomy as the Standard of Care in the US: Are We There Yet?
Cancers 2025cited by 4position: middledoi
Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases
Journal of Gastrointestinal Surgery 2024cited by 5position: middledoi
A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data
Annals of Surgical Oncology 2023cited by 27position: middledoi
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome
Hepatology 2023cited by 23position: middledoi
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2022cited by 1,680position: middledoi
Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States
Cancers 2022cited by 32position: middledoi
Discovering dominant tumor immune archetypes in a pan-cancer census
Cell 2021cited by 171position: middledoi
Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis
Annals of Surgical Oncology 2021cited by 25position: middledoi
Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era
Journal of Surgical Research 2020cited by 27position: lastdoi
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2019cited by 1,094position: middledoi
Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma
Abdominal Radiology 2017cited by 69position: middledoi
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis
Cell stem cell 2016cited by 141position: middledoi
Management of Postoperative Hepatic Failure
Journal of the American College of Surgeons 2015cited by 52position: middledoi
The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice
Gastroenterology 2014cited by 218position: middledoi
Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma
HPB 2014cited by 49position: middledoi
The TGR5 receptor mediates bile acid–induced itch and analgesia
Journal of Clinical Investigation 2013cited by 369position: lastdoi
The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts
Journal of Biological Chemistry 2013cited by 85position: lastdoi
The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice
Gastroenterology 2012cited by 338position: lastdoi
Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway
American Journal of Physiology-Gastrointestinal and Liver Physiology 2012cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric K. Nakakura · University of California, San Francisco6 papers (2020–2025)Adnan Alseidi · University of California, San Francisco5 papers (2021–2025)Kenzo Hirose · University of California, San Francisco5 papers (2020–2024)Mohamed A. Adam · Philips (Finland)5 papers (2021–2025)Nigel W. Bunnett · New York Proton Center5 papers (2012–2014)Daniel P. Poole · Monash University4 papers (2012–2014)Ajay V. Maker · University of California, San Francisco4 papers (2022–2025)Kimberly S. Kirkwood · University of California, San Francisco3 papers (2021–2023)Farzad Alemi · St Vincent Medical Center3 papers (2012–2013)TinaMarie Lieu · Johns Hopkins Medicine2 papers (2013–2014)Dane D. Jensen · New York University2 papers (2013–2014)Robert S. Warren · Center for Migration Studies of New York2 papers (2020–2024)Kristina Schoonjans · University of Lausanne2 papers (2012–2013)Fiore Cattaruzza · Sanofi (United States)2 papers (2012–2013)Martin Steinhoff · University of Freiburg2 papers (2013–2014)Alexander Monto · VA Greater Los Angeles Healthcare System2 papers (2014–2017)Amir Ashraf‐Ganjouei · University of California, San Francisco2 papers (2023–2025) · 2 papers (2013–2013)Lucia Calthorpe · University of California, San Francisco2 papers (2021–2022)Christoph Korbmacher · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2013–2014)